[Pharmacologic analysis of a new case of postanoxic intention and action myoclonus].
D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D002090:Butyrophenones / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D003128:Coma / Q000150:complications; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004724:Endoscopy / Q000009:adverse effects; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000150:complications*; D007490:Iproniazid / Q000494:pharmacology; D008728:Methotrimeprazine / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009207:Myoclonus / Q000188:drug therapy / Q000209:etiology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013569:Synapses / Q000187:drug effects
D002090:Butyrophenones; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D008728:Methotrimeprazine; D007490:Iproniazid; D009638:Norepinephrine; D008784:Methysergide
Analyse pharmacologique d'un nouveau cas de myoclonies d'intention et d'action post-anoxiques.